门静脉高压的分类及诊断思路

doi:10.3969/j.issn.1672-5069.2018.01.004

实用肝脏病杂志 ›› 2018, Vol. 21 ›› Issue (1): 14-17.doi: 10.3969/j.issn.1672-5069.2018.01.004

门静脉高压的分类及诊断思路

王帅, 祁小龙

100700 北京市解放军陆军总医院全军肝病治疗中心（王帅）;
南方医科大学南方医院肝病研究所（祁小龙）

收稿日期:2017-11-07 出版日期:2018-01-10 发布日期:2018-01-29
通讯作者: 祁小龙,E-mail: qixiaolong@vip.163.com
作者简介:王帅,男,44岁。主要从事肝硬化并发症及肝癌的防治研究。E-mail: shuai_shuai2006@163.com

Classification and diagnosis of portal hypertension

Wang Shuai, Qi Xiaolong

Institute of Hepatology,PLA Army General Hospital, Beijing 100700,China

Received:2017-11-07 Online:2018-01-10 Published:2018-01-29

摘要/Abstract

关键词: 门静脉高压, 分类, 诊断

Key words: Portal hypertension, Classification, Diagnosis

王帅, 祁小龙. 门静脉高压的分类及诊断思路[J]. 实用肝脏病杂志, 2018, 21(1): 14-17.

Wang Shuai, Qi Xiaolong. Classification and diagnosis of portal hypertension[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 14-17.

[1] 郑明华,Sherlock M. 肝胆病学. 12版. 北京：人民卫生出版社,2011:157.
[2] Webster GJ,Burroughs AK,Riordan SM. Portal vein thrombosis-new insight into artiology and management. Aliment. Pharmacol Therap,2005,21:1-9.
[3] Tsochazis EA,Senzolo M,Germani G,et al. Systemic review:portal vein thrombosis in cirrhosis. Aliment. Pharmacol Therap,2010,31:366-374.
[4] Levy C,Zein CO,Gomez J,et al. Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol,2007,5:803-808.
[5] Ludwing J,Hashimoto E,Obata H,et al. Idiopathic portal hypertension. Hepatology,1993,17:1157-1162.
[6] Weber SM,Rikkers LF. Splenic vein thrombosis and gastrointestinal bleeding in chronic pancreatitis. World J Surg, 2003,27:1271-1274.
[7] Shields SJ,Byse BH,Grace ND. Arteriopotal fisthla: a role for pre-TIPSS arteriography and hepatic venous pressure measurements. Am J Gastroenterol,1992,87:1828-1832.
[8] Goulis J,Patch D,Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet,1999,353:1102.
[9] Kleber G,Sauerbruch T,Ansari H,et al. Prediction of variceal hemorrhage in cirrhosis:a prospective follow-up study. Gastroenterology,1991,100:1332-1337.
[10] 中国医师协会腔内血管学专业委员会腔静脉阻塞专家委员会. 布加综合征亚型分型的专家共识. 临床肝胆病杂志,2017,33（7）:1229-1235.
[11] Hoekstra J,Leebeek FW,Plessier A,et al. Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome:findings form a cohort study. J Hepatol,2009,51:696-706.
[12] Hoekstra J,Guimaraes AHC,Leebeek FWG,et al. Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome. Blood,2010,115:388-395.
[13] Minnema MC. Budd-Chiari syndrome:combination of genetic defects and the use of oral contraceptives leading to hypercoagulability. J Hepatol,2000,33:509-512.
[14] Balian A,Valla D,Naveau S,et al. Post-traumatic membranous obstruction of the inferior vena cava associated with a hypercoagulable state. J Hepatol,1998,28:723-726.
[15] Gaiani S,Bolondi L,Li Bassi S,et al. Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Gastroenterology,1991,100:160-167.
[16] Iranmanesh P,Vazquez O,Terraz S,et al. Accurate computed tomography-based portal pressure assessment in patients with hepatocellular carcinoma. J Hepatol,2014,60:969-974.
[17] Qi X,Liu F,Li Z,et al. Insufficient accuracy of computed tomography-based portal pressure assessment in hepatitis B virus-related cirrhosis:An analysis of data from CHESS-1601 trial. J Hepatol,2017,[ahead of print].
[18] Qi X,Li Z,Huang J,et al. Virtual portal pressure gradient from anatomic CT angiography. Gut,2015,64:1004-1005.

门静脉高压的分类及诊断思路

Classification and diagnosis of portal hypertension

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	庄莹, 林志辉. 肝硬化并发门静脉血栓临床表现和诊断进展[J]. 实用肝脏病杂志, 2019, 22(6): 765-767.
[2]	中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会. 脂肪性肝病诊疗规范化的专家建议（2019年修订版）[J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
[3]	. 肝纤维化诊断及治疗共识（2019年）[J]. 实用肝脏病杂志, 2019, 22(6): 793-803.
[4]	吴海义, 陈建新. 四种诊断模型诊断乙型肝炎病毒携带者肝纤维化的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 832-835.
[5]	刘李, 杨烈, 陈海洋, 何承俊, 王建宇, 陈廷昊. 肝硬化门静脉高压症并发脾动脉盗血综合征患者脾切除联合贲门周围血管离断术后门脉血流动力学的变化^*[J]. 实用肝脏病杂志, 2019, 22(6): 884-887.
[6]	曹策, 郁义星, 王贝贝, 赵卫峰. 增强磁共振成像联合血清甲胎蛋白和脱-γ-羧基凝血酶原诊断肝细胞癌临床价值探讨[J]. 实用肝脏病杂志, 2019, 22(6): 896-899.
[7]	曾艳妮, 张灿, 毕俊英, 刘良进, 孟俊, 秦涛. MRI长时间延迟增强扫描诊断肝脏孤立性坏死性结节价值研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 900-903.
[8]	邢昊, 韩骏, 杨田. 应用血清PIVKA-II诊断肝细胞癌研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 934-937.
[9]	梁巨波, 苗琪, 马雄. 胆管细胞型胆汁淤积诊治进展[J]. 实用肝脏病杂志, 2019, 22(6): 941-943.
[10]	高伟, 侯勇. 肝脏硬度值检测诊断慢性乙型肝炎患者肝组织纤维化的效能分析*[J]. 实用肝脏病杂志, 2019, 22(5): 652-655.
[11]	黄汉军, 鲁凤荣, 张灿. 基于Exchange血流动力学模型的MRI扫描参数诊断肝硬化临床价值分析*[J]. 实用肝脏病杂志, 2019, 22(5): 696-699.
[12]	洪佳, 吴晓宁, 尤红. 胆汁淤积性肝病的规范化诊断[J]. 实用肝脏病杂志, 2019, 22(5): 758-760.
[13]	程华, 鞠辉, 宋德顺, 李伟. 慢性乙型肝炎患者血清血管生成素样蛋白2和高尔基体蛋白73水平变化及其诊断显著肝纤维化的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(4): 494-497.
[14]	余英芳, 温生宝. 应用磁共振DWI单指数、双指数和拉伸指数模型参数评估慢性乙型肝炎患者肝纤维化程度效能研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 502-505.
[15]	张亚飞, 叶珺, 谢琴秀, 邹桂舟, 李家斌, 李旭, 张振华. 不同医院无创性肝纤维化指标预测慢性乙型肝炎患者肝纤维化效能差异分析^*[J]. 实用肝脏病杂志, 2019, 22(4): 510-513.